The role of exogenous growth-promoting factors and their receptors in embryogenesis

Reproductive Toxicology

Volumn 12, Issue 2, 1998, Pages 201-207

  Pratten, Margaret K ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Embryo culture; Growth factors; Microcannulation; Yolk sac

Indexed keywords

ALPHA CYANOTHIOCAFFEIC ACID AMIDE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; GROWTH PROMOTOR; INSULIN; NITRILE; SOMATOMEDIN C;

ANIMAL; ANIMAL EXPERIMENT; CONFERENCE PAPER; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO GROWTH; FEMALE; FETUS DEVELOPMENT; HORMONE TRANSPORT; MICROINJECTION; NONHUMAN; ORGANOGENESIS; PHYSIOLOGY; PREGNANCY; RAT; RAT STRAIN; TISSUE CULTURE; YOLK SAC;

ANIMALIA; MAMMALIA;

EID: 0032034165     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00146-9     Document Type: Conference Paper

References (62)

1. 1. Rizzino A. Defining the roles of growth factors during early mammalian development. In: Bavister, BB, ed. The Mammalian preimplantation embryo: regulation of growth and differentiation in vitro. New York: Plenum Press; 1987:51-174.
2. 2. Mercola M, Stiles CD. Growth factor superfamilies and mammalian embryogenesis. Development. 1988;102:451-60.
3. 3. Basegra R, Rubin, R. Cell cycle and growth control. Crit Rev Gene Exp. 1993;3:47-61.
4. 4. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555-62.
5. 5. Sharpe PM, Brunet CL, Ferguson MWJ. Modulation of the epidermal growth factor of mouse embryonic mesenchymal cells in vitro by growth factors. Int J Dev Biol. 1992;36:275-82.
6. 6. Vaahtokari A, Aberg T, Thesleff I. Apoptosis in the developing tooth: association with an embryonic signaling center and suppression by EGF and FGF-4. Development. 1996;122:121-9.
7. 7. Brunet CL, Sharpe PM, Ferguson MWJ. The distribution of epidermal growth factor binding sites in the developing mouse palate. Int J Dev Biol. 1993;37:451-8.
8. 8. Sassani R, Bartlett SP, Feng H, Goldner-Sauve A, Haq AK, Buetow KH Gasser DC. Association between alleles of the transforming growth factor alpha locus and the occurrence of cleft lip. Am J Med Genet. 1993;45:565-9.
9. 9. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: relationship with growth in normal subjects and in subjects with intra-uterine growth retardation. Pediatr Res. 1991;29:219-25.
10. 10. Hill WC, Pelle-Day G, Kitzmille JL, Spencer EM. Insulin-like growth factors in fetal macrosomia with and without maternal diabetes. Hormone Res. 1989;32:178-82.
11. 11. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta1 knock out mice. Development. 1995;121:1845-54.
12. 12. Francis West P, Tickle C. Limb development. Curr Top Microbiol Immunol. 1996;212:239-59.
13. 13. Dealy CN, Kosher RA. IGF-I. insulin and FGFs induce outgrowth of the limb buds of amelic mutant chick embryos. Development. 1996;122:1323-30.
14. 14. Macias D, Ganan Y, Ros MA, Hurle JM. In vivo inhibition of programmed cell death by local administration of FGF-2 and FGF-4 in the interdigital areas of the embryonic chick leg bud. Anat Embryol. 1996;193:533-41.
15. 15. Gluckman PD. Role of pituitary hormones, growth factors and insulin in regulation of fetal growth. Oxf Rev Reprod Biol. 1986;8:1-60.
16. 16. Adamson ED. Growth factors in development. In: Warshaw JB, ed. The biologic basis of reproductive and developmental medicine. London: Edward Arnold: 1983:307-36.
17. 17. Adamson ED. EGF receptor activities in mammalian development. Mol Rep Dev. 1990;27:16-22.
18. 18. Adamson ED. Two proto-oncogenes that play dual roles in embryonal cell growth and differentiation. Int J Dev Biol. 1993; 37:111-16.
19. 19. Han V KM, D'Ercole AJ, Lund PK. Cellular localisation of somatomedia (insulin-like growth factor) messenger RNA in the human fetus. Science (Washington DC). 1987;236:193-7.
20. 20. Beck F, Samani NJ, Penshow JD, Thorley B, Tregear GW, Coghlan JP. Histochemieal localization of IGF-I and -II mRNA in the developing rat embryo. Development. 1987;101:175-84.
21. 21. Senior PV, Byrne S, Brammar WJ, Beck F. Expression of the IGF-II/mannose-6-phosphate receptor mRNA and protein in the developing rat. Development. 1990;109:67-73.
22. 22. Florance RSK, Senior PV, Byrne S, Beck F. The expression of IGF-II in the early post-implantation rat conceptus. J Anat. 1991;175:169-79.
23. 23. Twardzik DR, Ranchalis JE, Todaro GJ. Mouse embryonic transforming growth factors related to those isolated from tumour cells. Cancer Res. 1982;42:590-3.
24. 24. Huang L, Solursh M, Sandra A. The role of transforming growth factor alpha in craniofacial development and chondrogenesis. J Anat. 1996;189:73-86.
25. 25. Wilcox JN, Derynck R. Developmental expression of transforming growth factors alpha and beta in mouse fetus. Mol Cell Biol. 1988;8:3415-22.
26. 26. Shastry BS. More to learn from gene knockouts. Mol Cell Biochem. 1994;136:171-82.
27. 27. New DAT. Whole embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. 1978;53:81-122.
28. 28. Van Maele Fabry G, Delhaise F, Picard JJ. Morphogenesis and quantification of the development of postimplantation mouse embryos. Toxicol In Vitro. 1990;4:149-56.
29. 29. Lowry DH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with folin phenol reagent. J Biol Chem. 1951;193:265-75.
30. 30. Dunton A, Al-Alousi LA, Pratten MK, Beck F. The giant yolk sac: a model for studying early placental transport. J Anat. 1986;145: 189-206.
31. 31. Cumberland PFT, Richold M, Parsons J, Pratten MK Intravitelline injection of cultured rat embryos: An improved method for the identification of cytotoxic and non-cytotoxic teratogens. Toxicol In Vitro. 1992;6:503-8.
32. 32. Pratten MK, Brooke AM, Broome SC, Beck F. The effect of epidermal growth factor, insulin and transferrin on the growth promoting properties of serum depleted by repeated culture of postimplantation rat embryos. Development. 1988;104:137-45.
33. 33. Smith EP, Sadler TW, D'Ercole AJ. Somatomedins/insulin-like growth factors, their receptors and binding proteins are present during mouse embryogenesis. Development. 1987;101:73-82.
34. 34. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and post-natal growth. Cell. 1993;75: 73-82.
35. 35. Travers JP. Studies relating to rat diabetic embryotoxicity. Leicester, UK: University of Leicester, 1989. Thesis
36. 36. Travers JP, Exell L, Huang B, Town E, Lammiman MJ, Pratten MK, Beck F. Insulin and insulin-like growth factors in embryonic development: effects of a biologically inert insulin (guinea pig) upon rat embryonic growth and development in vitro. Diabetes. 1992;41:318-24.
37. 37. Travers JP, Pratten MK, Beck F. The effects of low insulin levels upon rat embryonic growth and development. Diabetes. 1989;38: 773-8.
38. 38. Sadler TW, Phillips, LS, Balkan W, Goldstein S. Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture. Diabetes. 1986;35:861-5.
39. 39. Balkan W, Phillips LS, Goldstein S, Sadler TW. Potential role of somatomedin inhibitors in the production of diabetic embryopathies. Teratology. 1988;37:271-82.
40. 40. Hunter ES, Phillips LS, Goldstein S, Sadler TW. Altered visceral yolk sac function produced by a low molecular-weight somatomedin inhibitor. Teratology. 1991;43:331-40.
41. 41. Balkan W, Phillips LS, Goldstein S, Sadler TW. Role of the mouse visceral yolk sac in nutrition: inhibition by a somatomedin inhibitor. J Exp Zool. 1989;249:36-40.
42. 42. Cowley EA, Pratten MK. Analysis of the receptor complement for insulin and insulin-like growth factor I (IGF-I) in the rat visceral yolk sac placenta. Biochem Soc Trans. 1992;20:280.
43. 43. Cowley EA, Pratten MK. Processing of fluorescently labelled insulin and insulin-like growth factor-I by the rat visceral yolk sac. Placenta. 1996;17:321-7.
44. 125I-labelled bovine serum albumin (BSA) by the rat visceral yolk sac cultured in vitro as a closed vesicle. Placenta. 1988;9 303-11.
45. 45. Ferguson MWJ, Sharpe PM, Thomas BL, Beck F. Differential expression of insulin-like growth factors i and ii (IGF I and II), mRNA, peptide and binding protein 1 during mouse palate development: comparison with TGF beta peptide distribution. J Anat. 1992;181:219-38.
46. 46. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1r) Cell. 1993;75: 59-72.
47. 47. Tebbs CA, Cumberland PFT, Pratten MK. The role of maternally derived epidermal growth factor receptor during organogenesis in the rat embryo. J. Anal 1997;190:491-503.
48. 48. Andrews KE, Pratten MK, Beck F. Epidermal growth factor: pinocytosis and effect on embryonic development. Biochem Soc Trans. 1987;15:920-1.
49. 49. Nexo E, Hollenberg MD, Figueroa A, Pratt RM. Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. Proc Natl Acad Sci USA. 1980;77:2782-95.
50. 50. Adamson ED, Meek J. The ontogeny of EGF receptors during mouse development. Dev Biol. 1984;103:62-70.
51. 51. Hortsch M, Schlessinger J, Gootwine F, Webb CG. Appearance of functional EGF receptor kinase during rodent embryogenesis. EMBO J. 1983;2:1937-41.
52. 52. Paria BC, Dey SK. Pre-implantation embryo development in vitro: cooperative interactions among embryos and role of growth factors. Proc Natl Acad Sci USA. 1990;87:4756-60.
53. 53. Popliker M, Shatz A, Avivi A, Ullrich A, Schlessinger J, Webb CG. Onset of endogenous synthesis of epidermal growth factor in neonatal mice. Dev Biol. 1987;119:38-44.
54. 54. Raaberg L, Nexo E, Damsgaard-Mikkelsen J, Poulsen SS. Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry. 1988;89:351-6.
55. 55. Huet-Hudson YM, Andrew GK, Dey SK. Epidermal growth factor and pregnancy in the mouse. In: Hener S, Wiley LM, eds. Early embryo development and paracrine relationship. New York: Wiley-Liss; 1990:125-36.
56. 56. Adamson ED, Deller MJ, Warshaw JB. Functional EGF receptors are present on mouse embryo tissues. Nature (Lond.). 1981;291: 656-9.
57. 57. Adamson D, Growth-factors and their receptors in development. Dev Genet (Amsterdam). 1993;14:159-64.
58. 58. Sibilia M, Wagner FE. Strain dependent epithelial defects in mice lacking EGF receptor. Science (Washington DC). 1995; 269:230-3.
59. 59. Threadgill DW, Dlusgosz AJ, Hansen LA, Tennenbaum T, Lichti U, Yee D, Lamanti C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnussen T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science (Washington DC). 1995;269:230-3.
60. 60. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair and curly whiskers and often develop corneal inflammation. Cell. 1993;73:249-61.
61. 61. Luetteke NC, Qui TH, Peiffer RL, Oliver P, Smithies O, Lee DC. TGFalpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 1993;73:263-78.
62. 62. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 1994;8:399-413.